Empagliflozin Trial to Reduce Arterial Stiffness in Older Adults
Phase 2/3
80
about 4.5 years
60–80
1 site in MO
Why this study is shown
What this study is about
Researchers are testing whether empagliflozin, a medication, can help reduce arterial stiffness in older adults. The trial involves randomly assigning participants aged 60-80 to either empagliflozin or a placebo for 12 weeks. It will last approximately 1655 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Empagliflozin 10 MG
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
empagliflozin (SGLT2 inhibitor; increases glucose excretion in urine)
Primary: Carotid Femoral Pulse Wave Velocity (cfPWV)